Mechanics of COVID-19 Vaccine IP Waiver in View of Trade-Related Aspects of IP Rights

Publication Date12 May 2021
SubjectWTO,Life Sciences,Patent Ownership,Vaccinations,TRIPS Agreement,Infectious Diseases,Pharmaceutical Industry,Patient Access,Coronavirus/COVID-19,Biden Administration
AuthorDion Bregman,Christopher Halliday
Law FirmMorgan Lewis

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT